Repeated cross-sectional survey of patient-reported asthma control in europe in the past 5 years

European Respiratory Review

Volumn 21, Issue 123, 2012, Pages 66-74

  Demoly, P ^a   Annunziata, K ^b   Gubba, E ^c   Adamek, L ^d  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b KANTAR HEALTH   (United States)

^c Post Synaptic Ltd   (United Kingdom)

^d GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Adults; Asthma control; Cross sectional surveys; Europe

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LONG ACTING DRUG; SHORT ACTING DRUG;

ABSENTEEISM; ANXIETY; ARTICLE; ASTHMA; COHORT ANALYSIS; COMORBIDITY; CROSS-SECTIONAL STUDY; DEPRESSION; DIABETES MELLITUS; DISEASE CONTROL; EUROPE; HEALTH CARE; HEALTH CARE UTILIZATION; HEALTH STATUS; HUMAN; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRODUCTIVITY; QUALITY OF LIFE; SEX DIFFERENCE; SMOKING; WELLBEING;

ADOLESCENT; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; CROSS-SECTIONAL STUDIES; EUROPE; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; RETROSPECTIVE STUDIES; SELF REPORT; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84857834051     PISSN: 09059180     EISSN: 16000617     Source Type: Journal    
DOI: 10.1183/09059180.00008111     Document Type: Article

References (35)

1. World Health Organization Asthma fact sheet. Date last accessed: September 2011. Date last updated: May 2011. www.who.int/mediacentre/factsheets/fs307/en/index.html
2. Accordini S, Corsico A, Cerveri I, et al. The socio-economic burden of asthma is substantial in Europe. Allergy 2008; 63: 116-124.
3. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention (updated 2010). www.ginasthma.com
4. Masoli M, Fabian D, Holt S, et al. The global burden of asthma: executive summary of the GINA Dissemination Committee Report. Allergy 2004; 59: 469-478.
5. National Asthma Education and Prevention Program: Expert Panel Report 3. Guidelines for the Diagnosis and Management of Asthma. Bethesda, National Institutes of Health, 2007.
6. Vollmer W, Markson LE, O'Connor E, et al. Association of asthma control with healthcare utilisation and quality of life. Am J Respir Crit Care Med 1999; 160: 1647-1652.
7. Guilbert TW, Garris C, Jhingran P, et al. Asthma that is not well-controlled is associated with increased healthcare utilization and decreased quality of life. J Asthma 2011; 48: 126-132.
8. Strine TW, Mokdad AH, Balluz LS, et al. Impact of depression and anxiety on quality of life, health behaviors, and asthma control among adults in the United States with asthma, 2006. J Asthma 2008; 45: 123-133.
9. Cluely S, Cochrane GM. Psychological disorder in asthma is associated with poor control and poor adherence to inhaled steroids. Respir Med 2001; 95: 37-39.
10. Fernandes L, Fonseca J, Martins S, et al. Association of anxiety with asthma: subjective and objective outcome measures. Psychosomatics 2010; 51: 39-46.
11. Di Marco, Verga M, Santus P, et al. Close correlation between anxiety, depression and asthma control. Respir Med 2010; 104: 22-28.
12. Accordini S, Bugiani M, Arossa W, et al. Poor control increases the economic cost of asthma. A multicentre population-based study. Int Arch Allergy Immunol 2006; 141: 189-198.
13. Van Ganse E, Laforest L, Pietri G, et al. Persistent asthma: disease control, resource utilisation and direct costs. Eur Respir J 2002; 20: 260-267.
14. Demoly P, Paggiaro P, Plaza V, et al. Prevalence of asthma control among adults in France, Germany, Italy, Spain and the UK. Eur Respir Rev 2009; 18: 105-112.
15. Demoly P, Gueron B, Annunziata K, et al. Updateon asthma control in five European countries. Eur Respir Rev 2010; 19: 150-157.
16. Nathan RA, Sorkness CA, Kosinski, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004; 113: 59-65.
17. Ware JE, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220-233.
18. Samsa G, Edelman D, Rothman ML, et al. Determining clinically important differences in health status measures. A general approach with illustration to the health utilities index mark II. Pharmacoeconomics 1999; 15: 141-155.
19. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproduci-bility of a work productivity and activity impairment instrument. Pharmacoeconomics 1993; 4: 353-65.
20. Mintz M, Gilsenan AW, Bui CL, et al. Assessment of asthma control in primary care. Curr Med Res Opin 2009; 25: 2423-2531.
21. Peters SP, Jones CA, Haselkorn T, et al. Real-world evaluation of asthma control and treatment (REACT): findings from a national web-based survey. J Allergy Clin Immunol 2007; 119: 1454-61.
22. Chapman KR, Boulet LP, Rea RM, et al. Suboptimal asthma control: prevalence, detection and consequences in general practice. Eur Respir J 2008; 31: 320-325.
23. Cazzoletti L, Marcon A, Janson C, et al. Asthma control in Europe: a real-world evaluation based on an international population-based study. J Allergy Clin Immunol 2007; 120: 1360-1367.
24. Omenaas E, Svanes C, Janson C, et al. What can we learn about asthma and allergy from the follow-up of the RHINE and the ECRHS studies? Clin Respir J 2008; 2: 45-52.
25. Bellamy D, Harris T. Poor perceptions and expectations of asthma control: results of the International Control of Asthma Symptoms (ICAS) survey of patients and general practitioners. Prim Care Respir J 2005; 14: 252-258.
26. Van Ganse E, Antonicelli L, Zhang Q, et al. Asthma-related resource use and cost by GINA classification of severity in three European countries. Respir Med 2006; 100: 140-147.
27. Rabe KF, Vermeire PA, Soriano JB, et al. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000; 16: 802-807.
28. Prieto L, Badiola C, Villa JR, et al. Asthma control: do patients' and physicians' opinions fit in with patients' asthma control status? J Asthma 2007; 44: 461-467.
29. Kardos P, Wittchen H-U, Mühlig S, et al. Controlled and uncontrolled allergic asthma in routine respiratory specialist care - a clinical-epidemiological study in Germany. Curr Med Res Opin 2011; 27: 1835-1847.
30. Juniper EF, Chauhan A, Neville E, et al. Clinicians tend to overestimate improvements in asthma control: an unexpected observation. Prim Care Respir J 2004; 13: 181-184.
31. Small M, Vickers A, Anderson P, et al. The patient-physician partnership in asthma: real-world observations associated with clinical and patient-reported outcomes. Adv Ther 2010; 27: 591-599.
32. Kaya Z, Erkan F, Ozkan M, et al. Self-management plans for asthma control and predictors of patient compliance. J Asthma 2009; 46: 270-272.
33. Yawn BP. Factors accounting for asthma variability: achieving optimal symptom control for individual patients. Prim Care Respir J 2008; 17: 138-147.
34. Soriano JB, Rabe KF, Vermeire PA. Predictors of poor asthma control in European adults. J Asthma 2003; 40: 803-813.
35. Pont LG, van der Molen T, Denig P, et al. Relationship between guideline treatment and health-related quality of life in asthma. Eur Respir J 2004; 23: 718-722.